Matinas BioPharma Holdings, Inc. (MTNB)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-214.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $1.10M | $3.19M | $33.0K | $158.3K | $89.8K | $119.8K | — | — |
| Operating Income | -$6.96M | -$24.59M | -$23.77M | -$24.59M | -$24.73M | -$24.21M | -$18.92M | -$14.65M | -$16.50M | -$8.26M |
| Net Income | -$10.35M | -$24.25M | -$22.94M | -$21.00M | -$23.28M | -$22.45M | -$17.37M | -$14.08M | -$15.49M | -$7.60M |
| EPS (Diluted) | $-2.00 | $-4.98 | $-5.28 | $-0.10 | $-0.11 | — | — | — | — | — |
| Total Assets | $7.21M | $12.64M | $25.10M | $44.82M | $61.33M | $70.97M | $40.24M | $19.94M | $14.42M | $9.82M |
| Total Liabilities | $2.38M | $5.05M | $5.86M | $8.18M | $8.83M | $7.24M | $7.19M | $3.80M | $3.74M | $2.67M |
| Shareholders' Equity | $4.83M | $7.59M | $19.25M | $36.64M | $52.49M | $63.73M | $33.05M | $16.14M | $10.68M | $7.15M |
| Cash & Equivalents | $4.00M | $7.28M | $4.79M | $6.83M | $21.03M | $12.43M | $22.17M | $12.45M | $7.31M | $4.11M |
| Operating Cash Flow | -$7.01M | -$15.88M | -$15.28M | -$19.16M | -$15.22M | -$17.37M | -$14.09M | -$10.32M | -$11.46M | -$6.12M |
| Capital Expenditures | — | — | $218.0K | $892.0K | $260.0K | $5.7K | $405.6K | $535.9K | $942.2K | $0 |
| Shares Outstanding | 6.41M | 5.09M | 4.35M | 217.26M | 216.27M | 200.11M | 163.16M | 113.29M | 93.37M | 58.16M |